--- title: "Beijing Biostar Pharmaceuticals Co. (2563) stock" url: "https://aibio.space/companies/beijing-biostar-pharmaceuticals/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Beijing Biostar Pharmaceuticals Co., Ltd. (HKEX: 2563), China. The directory classifies it as Pharmaceuticals: Major." --- 2563 Beijing Biostar Pharmaceuticals Co., Ltd. HKEX · China # Beijing Biostar Pharmaceuticals Co. (2563) news Beijing Biostar Pharmaceuticals Co., Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 2563, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest Beijing Biostar Pharmaceuticals Co. news We have not published a story on Beijing Biostar Pharmaceuticals Co. yet. When there is news, it will appear here. ## Beijing Biostar Pharmaceuticals Co. at a glance - **Ticker**: 2563 - **Listing**: HKEX - **Country**: China ### Related companies - [Hanshang Group Co.](https://aibio.space/companies/hanshang/) SSE: 600774 - [Guizhou Bailing Group Pharmaceutical Co.](https://aibio.space/companies/guizhou-bailing-pharmaceutical/) SZSE: 002424 - [Zhejiang Shengda Bio-Pharm Co.](https://aibio.space/companies/zhejiang-shengda-bio-pharm/) SSE: 603079 - [Golden Throat Holdings Group Co](https://aibio.space/companies/golden-throat/) HKEX: 6896 - [Hinova Pharmaceuticals](https://aibio.space/companies/hinova-pharmaceuticals/) SSE: 688302 - [Guangzhou Baiyunshan Pharmaceutical Holdings Company](https://aibio.space/companies/guangzhou-baiyunshan-pharmaceutical/) SSE: 600332 - [Shenyang Xingqi Pharmaceutical Co.](https://aibio.space/companies/shenyang-xingqi-pharmaceutical/) SZSE: 300573 - [CASI Pharmaceuticals](https://aibio.space/companies/casi-pharmaceuticals/) OTC: CASIF ### Also on HKEX - [Grand Pharmaceutical Group](https://aibio.space/companies/grand-pharmaceutical/) 512 - [Zhejiang Laifual Drive Co.](https://aibio.space/companies/zhejiang-laifual-drive/) 3952 - [Brii Biosciences](https://aibio.space/companies/brii-biosciences/) 2137 - [Fusen Pharmaceutical Co.](https://aibio.space/companies/fusen-pharmaceutical/) 1652 - [Hygeia Healthcare Holdings Co.](https://aibio.space/companies/hygeia-healthcare/) 6078 - [Sihuan Pharmaceutical Holdings Group](https://aibio.space/companies/sihuan-pharmaceutical/) 460 ## Questions about Beijing Biostar Pharmaceuticals Co. What is the ticker symbol of Beijing Biostar Pharmaceuticals Co.? Beijing Biostar Pharmaceuticals Co., Ltd. trades under the ticker 2563 on HKEX. Where is Beijing Biostar Pharmaceuticals Co. listed? Beijing Biostar Pharmaceuticals Co., Ltd. is listed on HKEX. Which country or territory is Beijing Biostar Pharmaceuticals Co. listed under? Our directory records Beijing Biostar Pharmaceuticals Co., Ltd. under China. What does Beijing Biostar Pharmaceuticals Co. do? Our directory classifies Beijing Biostar Pharmaceuticals Co., Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline. What is the ISIN of Beijing Biostar Pharmaceuticals Co.? The ISIN recorded for Beijing Biostar Pharmaceuticals Co., Ltd. is CNE100006NB3. Does aibio.space cover Beijing Biostar Pharmaceuticals Co.? aibio.space lists Beijing Biostar Pharmaceuticals Co., Ltd. among 2,820 public biotech companies and publishes its news here as stories appear. Which companies are similar to Beijing Biostar Pharmaceuticals Co.? Companies in our directory listed in the same country and business area as Beijing Biostar Pharmaceuticals Co.: Hanshang Group Co., Guizhou Bailing Group Pharmaceutical Co., Zhejiang Shengda Bio-Pharm Co., Golden Throat Holdings Group Co, Hinova Pharmaceuticals, Guangzhou Baiyunshan Pharmaceutical Holdings Company. ## Investor discussion: Beijing Biostar Pharmaceuticals Co. Members talk about Beijing Biostar Pharmaceuticals Co. (2563). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Beijing Biostar Pharmaceuticals Co., newest first. Each line links the filing it comes from. 1. 2026-07-16 Financings Share or debt issue: COMPLETION OF SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0716/2026071600539.pdf) 2. 2026-05-28 Financings Share or debt issue: (1) 2025 ANNUAL RESULTS & DIVIDEND; (2) CONNECTED TRANSACTIONS; (3) APPOINTMENT OF DIRECTOR & AUDITOR; (4) GENERAL & REPURCHASE MANDATES; (5) CANCELLATION OF THE SUPERVISORY COMMITTEE AND AMENDMENTS TO ARTICLES OF ASSOCIATION; (6) SHARE OPTION SCHEME; AND NOTICE OF THE ANNUAL GENERAL MEETING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0528/2026052802403.pdf) 3. 2026-05-21 Financings Share or debt issue: SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0521/2026052101400.pdf) 4. 2026-05-07 Financings Share or debt issue: SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0507/2026050702410.pdf) 5. 2025-07-24 Financings Share or debt issue: (1) 2024 REPORT OF THE BOARD; (2) 2024 REPORT OF THE SUPERVISORY COMMITTEE; (3) 2024 AUDITED CONSOLIDATED FINANCIAL STATEMENTS; (4) 2024 ANNUAL REPORT; (5) PROFIT DISTRIBUTION PLAN OF THE COMPANY FOR THE YEAR 2024; (6) REMUNERATION OF DIRECTORS FOR THE YEAR 2025; (7) REMUNERATION OF SUPERVISORS FOR THE YEAR 2025; (8) PROPOSED APPOINTMENT OF AUDITOR FOR 2025; (9) PROPOSED GRANTING OF GENERAL MANDATE TO REPURCHASE H SHARES; AND NOTICE OF THE ANNUAL GENERAL MEETING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0724/2025072401836.pdf) 6. 2025-07-02 Listings Trading status: EXCHANGE NOTICE - RESUMPTION OF TRADING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0702/2025070200193.htm) 7. 2025-06-30 Listings Trading status: (1) QUARTERLY UPDATE ON STATUS OF RESUMPTION; AND (2) RESUMPTION OF TRADING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0630/2025063003980.pdf) 8. 2025-04-01 Listings Trading status: EXCHANGE NOTICE - SUSPENSION OF TRADING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0401/2025040100207.htm) 9. 2025-03-31 Listings Trading status: DELAY IN PUBLICATION OF THE 2024 ANNUAL RESULTS; AND POSSIBLE SUSPENSION OF TRADING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0401/2025033102127.pdf) ## Press releases Headlines of Beijing Biostar Pharmaceuticals Co.'s own announcements, newest first. Each opens the full release on the newswire that carried it. 1. 2026-10-20 HKEXnews [VOLUNTARY ANNOUNCEMENT - UTD2 OF BIOSTAR ACHIEVES FIRST PATIENT DOSING IN PHASE III CLINICAL STUDY FOR HER2-NEGATIVE ADVANCED BREAST CANCER](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1020/2026102000799.pdf) 2. 2026-08-26 HKEXnews [INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0826/2026082602061.pdf) 3. 2026-07-16 HKEXnews [COMPLETION OF SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0716/2026071600539.pdf) 4. 2026-06-26 HKEXnews [POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 26 JUNE 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0626/2026062602469.pdf) 5. 2026-06-11 HKEXnews [SUPPLEMENTAL NOTICE OF ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0612/2026061200015.pdf) 6. 2026-06-11 HKEXnews [SUPPLEMENTAL CIRCULAR (1) CLARIFICATION AND WITHDRAWAL OF ORDINARY RESOLUTION IN RELATION TO THE CONNECTED TRANSACTION; (2) PROPOSED RE-APPOINTMENT OF AUDITOR FOR 2026; (3) WITHDRAWAL OF SPECIAL RESOLUTIONS IN RELATION TO SHARE OPTION SCHEME; AND SUPPLEMENTAL NOTICE OF THE ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0612/2026061200013.pdf) 7. 2026-05-28 HKEXnews [NOTICE OF ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0528/2026052802461.pdf) 8. 2026-05-28 HKEXnews [(1) 2025 ANNUAL RESULTS & DIVIDEND; (2) CONNECTED TRANSACTIONS; (3) APPOINTMENT OF DIRECTOR & AUDITOR; (4) GENERAL & REPURCHASE MANDATES; (5) CANCELLATION OF THE SUPERVISORY COMMITTEE AND AMENDMENTS TO ARTICLES OF ASSOCIATION; (6) SHARE OPTION SCHEME; AND NOTICE OF THE ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0528/2026052802403.pdf) 9. 2026-05-27 HKEXnews [VOLUNTARY ANNOUNCEMENT - FOUR CLINICAL STUDY RESULTS OF UTIDELONE OF BIOSTAR PHARMACEUTICALS SELECTED FOR THE 2026 AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) ANNUAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0527/2026052701902.pdf) 10. 2026-05-26 HKEXnews [CLARIFICATION ANNOUNCEMENT IN RELATION TO PROPOSED ADOPTION OF SHARE OPTION SCHEME](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0526/2026052600872.pdf) 11. 2026-05-21 HKEXnews [SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0521/2026052101400.pdf) 12. 2026-05-07 HKEXnews [PROPOSED ADOPTION OF SHARE OPTION SCHEME AND PROPOSED MANDATE TO THE BOARD AND/OR AUTHORISED PERSON TO HANDLE MATTERS PERTAINING TO THE SHARE OPTION SCHEME](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0507/2026050702416.pdf) 13. 2026-05-07 HKEXnews [SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0507/2026050702410.pdf) 14. 2026-05-07 HKEXnews [VOLUNTARY ANNOUNCEMENT - INTENTION TO CONDUCT ON-MARKET SHARE REPURCHASE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0507/2026050702402.pdf) 15. 2026-04-28 HKEXnews [RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR; NON-COMPLIANCE WITH THE LISTING RULES; AND PROPOSED APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0428/2026042804353.pdf) 16. 2026-03-31 HKEXnews [ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0331/2026033004288.pdf) 17. 2026-03-30 HKEXnews [INSIDE INFORMATION - LISTING APPROVAL GRANTED BY THE STOCK EXCHANGE FOR THE FULL CIRCULATION OF SHARES BY THE COMPANY](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0330/2026033003590.pdf) 18. 2026-03-25 HKEXnews [SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO EXPECTED QUALIFIED OPINION](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0325/2026032502265.pdf) 19. 2026-03-25 HKEXnews [INSIDE INFORMATION - EXPECTED QUALIFIED OPINION](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0325/2026032500283.pdf) 20. 2026-02-06 HKEXnews [INSIDE INFORMATION - ISSUANCE OF FILING NOTICE BY THE CSRC FOR THE FULL CIRCULATION OF SHARES BY THE COMPANY](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0206/2026020601378.pdf) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open HKEX:2563 on TradingView](https://www.tradingview.com/symbols/HKEX-2563/). ## Listing details Beijing Biostar Pharmaceuticals Co., Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 2563, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Beijing Biostar Pharmaceuticals Co., Ltd. - **Ticker**: 2563 - **Listing**: HKEX - **Country or territory**: China - **Business scope**: Pharmaceuticals: Major - **ISIN**: CNE100006NB3 - **Last quote in directory**: 2026-10-22 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/HKEX-2563/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/beijing-biostar-pharmaceuticals/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Beijing Biostar Pharmaceuticals Co. (2563) stock", 2026-10-31, https://aibio.space/companies/beijing-biostar-pharmaceuticals/